1. P1593: IMMUNE BIOMARKERS TO PREDICT SARS-COV-2 VACCINE EFFECTIVENESS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES. (23rd June 2022) Authors: Tamariz-Amador, L.-E.; Battaglia, A. M.; Maia, C.; Zherniakova, A.; Guerrero, C.; Zabaleta, A.; Burgos, L.; Botta, C.; Fortuño, M.-A.; Alignani, D.; Blanco, L.; Grande, C.; Manubens, A.; Arguiñano, J.-M.; Gomez, C.; Perez-Persona, E.; Olazabal, I.; Oiartzabal, I.; Panizo, C.; Prosper, F. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1474 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P862: SERUM MASS SPECTROMETRY TO ANALYZE DISEASE RESPONSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING ARI0002H, AN ACADEMIC BCMA-DIRECTED CAR T-CELL THERAPY. (23rd June 2022) Authors: Ortiz De Landazuri, I.; Oliver-Caldés, A.; Español-Rego, M.; Contreras, M. T.; Zabaleta, A.; Agulló, C.; Puig, N.; Cabañas, V.; González-Calle, V.; Jiménez, R.; Inogés, S.; Rodríguez-Otero, P.; Martin-Antonio, B.; Reguera, J. L.; López-Diaz de Cerio, A.; Benítez-Ribas, D.; Rodríguez-Lobato, L. G.... Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 755 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗